Human babesiosis: The past, present and future
Expert Reviews in Molecular Medicine · 2025 · 27
DOI: 10.1017/erm.2025.10016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 05.09.2025. Verfasst von Madison Asquith und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Applied Sciences, https://ror.org/05t1h8f27University of Huddersfield, Huddersfield, UK. Hauptthemen laut MEDLINE: Babesiosis, Babesia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human babesiosis is a disease transmitted by the bite of an infected tick or via blood transfusions involving contaminated blood products; in humans, it can lead to severe complications and even death, depending on the clinical history, age and health status of the affected patient. Babesiosis is caused by members of the Babesia spp., protozoan parasites whose life cycle includes sexual reproduction in the arthropod vector and asexual reproduction in the mainly mammalian host. Cases of human babesiosis have been rare, but there are increasing reports of human babesiosis associated with climatic changes affecting the geographical distribution of the parasite and tick vector, enhanced vector–human interactions and improved awareness of the disease in humans. Diagnostics and treatment options for humans are based around discoveries in veterinary research, such as point-of-care testing in cases of bovine babesiosis, and include direct diagnosis by blood smears, polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) technologies, and indirect diagnosis by ELISA, immunofluorescence tests (IFAT) and fluorescent in situ hybridisation. Treatment involves a combination of drugs such as azithromycin and atovaquone, or clindamycin and quinine, but more effective options are being investigated, including, but not limited to, trans-chalcones and tafenoquine. Improved surveillance, awareness and diagnosis, as well as advanced technologies to interrupt vector–host interactions, are crucial in managing the increased threat posed by this once-neglected disease in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Applied Sciences, https://ror.org/05t1h8f27University of Huddersfield, Huddersfield, UK.
ORCID-Profile: Sally Prior, Anke Brüning-Richardson
Zitieren
APA
Asquith, M., Prior, S., & Brüning-Richardson, A. (2025). Human babesiosis: The past, present and future. Expert Reviews in Molecular Medicine, 27. https://doi.org/10.1017/erm.2025.10016
Vancouver
Asquith M, Prior S, Brüning-Richardson A. Human babesiosis: The past, present and future. Expert Reviews in Molecular Medicine. 2025;27. doi:10.1017/erm.2025.10016
BibTeX
@article{Asquith2025,
author = {Asquith, Madison and Prior, Sally and Brüning-Richardson, Anke},
title = {Human babesiosis: The past, present and future},
journal = {Expert Reviews in Molecular Medicine},
year = {2025},
volume = {27},
doi = {10.1017/erm.2025.10016}
}
EUVIMED